Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Dec;83(23):9114-8.
doi: 10.1073/pnas.83.23.9114.

Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic

Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic

A M Duijvestijn et al. Proc Natl Acad Sci U S A. 1986 Dec.

Abstract

One of the most striking examples of localized vascular differentiation is exhibited by specialized lymphoid organ venules that mediate the extravasation of circulating lymphocytes from the blood. These vessels are characterized by cuboidal or "high" endothelial cell morphology and are unique in their functional capacity to interact with migrating lymphocytes, regulating both the rate and specificity of lymphocyte traffic through particular regions of the body. We describe here a monoclonal antibody, MECA-325, that defines an endothelial cell differentiation antigen selectively expressed on high endothelium in the mouse. Thus an antigen defining a specific functional subset of endothelial cells has been found. Furthermore, we demonstrate that the MECA-325 antigen can be induced in mouse lung or bone marrow-derived endothelial cell lines in vitro by interferon-gamma but not by interferon-beta, interleukin-1, or endothelial cell mitogens. The results define a unique marker associated with differentiated endothelial cells mediating lymphocyte traffic from the blood, and they provide evidence that the specialized phenotype of these high endothelial cells may be induced and controlled by local factors associated with immune activity.

PubMed Disclaimer

References

    1. Int Rev Exp Pathol. 1980;21:119-94 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1964 Jan 14;159:257-82 - PubMed
    1. Dev Biol. 1981 May;84(1):183-92 - PubMed
    1. Hum Immunol. 1981 Nov;3(3):209-30 - PubMed
    1. J Histochem Cytochem. 1982 Feb;30(2):165-70 - PubMed

Publication types

LinkOut - more resources